CYCLOPHARM LTD

ASX: CYC (CYCLOPHARM FPO [CYC])

Last update: 3 days ago, 4:34PM

0.360

-0.01 (-2.70%)

Previous Close 0.370
Open 0.370
Volume 218,135
Avg. Volume (3M) 66,959
Market Cap 45,264,292
Price / Earnings (Forward) 116.28
Price / Sales 2.99
Price / Book 1.82
52 Weeks Range
0.330 (-8%) — 1.29 (258%)
Earnings Date 25 Aug 2025 - 29 Aug 2025
Profit Margin -47.87%
Operating Margin (TTM) -49.16%
Diluted EPS (TTM) -0.130
Quarterly Revenue Growth (YOY) 43.00%
Total Debt/Equity (MRQ) 19.39%
Current Ratio (MRQ) 3.99
Operating Cash Flow (TTM) -12.57 M
Levered Free Cash Flow (TTM) -10.21 M
Return on Assets (TTM) -16.80%
Return on Equity (TTM) -35.20%

Market Trend

Short Term Medium Term
Industry Medical Devices (AU) Mixed Mixed
Medical Devices (Global) Mixed Mixed
Stock CYCLOPHARM FPO [CYC] - -

AIStockmoo Score

-1.1
Analyst Consensus 0.0
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages -2.5
Technical Oscillators -2.5
Relative Valuation NA
Financial Health NA
AI Insight NA
Weighted Average -1.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
CYC 45 M - - 1.82
LDX 86 M - - 3.32
SOM 64 M - - 1.51
MX1 44 M - - 6.23
HMD 37 M - - 15.12
CBL 30 M - - 4.99

Select this tab to load the latest available analysis.

Cyclopharm Ltd is a health technology company offering solutions related to functional lung ventilation imaging. Its proprietary product Technegas is a broad-spectrum diagnostic lung imaging technology product for the visualisation of pulmonary ventilation and lung function. The company sells its products to healthcare institutions and medical professionals. Maximum revenue is generated from its Technegas products and services, which include the sale of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. Geographically, the company generates maximum revenue from its business in Europe, and the rest from Asia Pacific, Canada, the USA, and other regions.

Sector Healthcare
Industry Medical Devices
Investment Style Small Value
% Held by Insiders 48.68%
% Held by Institutions 21.62%

No data within this time range.

No data within this time range.

AI Technical Analysis

Open the Technical tab to generate the latest analysis.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria